# OnCo record fort (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/fort/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "fort", "NCT00310167" ;
  schema:name "FoRT"@en ;
  schema:alternateName "FORT"@en, "FoRT trial"@en ;
  schema:description "FoRT asked whether two very small doses of radiotherapy control follicular lymphoma as well as the standard twelve; they do not, with about three times the rate of regrowth in the treated area, so 24 Gy stays the standard when the aim is lasting control and 4 Gy is kept for palliation."@en ;
  schema:url <https://onco.cc/trials/fort/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00310167> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/technologies/palliative-radiotherapy/> ;
  onco:institutions <https://onco.cc/institutions/uclh/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014/>, <https://onco.cc/key-papers/paper-fort-long-term-follow-up-hoskin-lancet-oncol-2021/> .